GlaxoSmithKline (GSK) Given “Buy” Rating at Liberum Capital

Liberum Capital reaffirmed their buy rating on shares of GlaxoSmithKline (LON:GSK) in a research note released on Monday. They currently have a GBX 1,760 ($23.87) price target on the stock.

GSK has been the topic of several other research reports. JPMorgan Chase & Co. restated a neutral rating and issued a GBX 1,570 ($21.29) price target on shares of GlaxoSmithKline in a research report on Monday, October 2nd. Beaufort Securities restated a buy rating and issued a GBX 1,800 ($24.41) price target on shares of GlaxoSmithKline in a research report on Monday, October 23rd. Shore Capital reiterated a hold rating on shares of GlaxoSmithKline in a research report on Wednesday, September 20th. UBS Group upgraded shares of GlaxoSmithKline to a buy rating and set a GBX 1,550 ($21.02) price objective on the stock in a research report on Monday, November 27th. Finally, Societe Generale reiterated a sell rating on shares of GlaxoSmithKline in a research report on Thursday, November 9th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of GBX 1,565.24 ($21.23).

Shares of GlaxoSmithKline (LON GSK) opened at GBX 1,359.20 ($18.43) on Monday. GlaxoSmithKline has a 1 year low of GBX 1,270 ($17.22) and a 1 year high of GBX 1,724.50 ($23.39). The firm has a market cap of $67,390.00 and a price-to-earnings ratio of 2,831.67.

GlaxoSmithKline (LON:GSK) last announced its quarterly earnings results on Wednesday, October 25th. The company reported GBX 32.50 ($0.44) earnings per share for the quarter, topping the consensus estimate of GBX 31.80 ($0.43) by GBX 0.70 ($0.01). GlaxoSmithKline had a net margin of 17.79% and a return on equity of 461.88%. The company had revenue of GBX 784.30 billion for the quarter.

The firm also recently disclosed a dividend, which was paid on Thursday, January 11th. Investors of record on Thursday, November 9th were paid a GBX 19 ($0.26) dividend. This represents a yield of 1.41%. The ex-dividend date was Thursday, November 9th.

In related news, insider Patrick Vallance sold 20,000 shares of the company’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of GBX 1,310 ($17.77), for a total value of £262,000 ($355,302.41). Also, insider Urs Rohner acquired 473 shares of the stock in a transaction that occurred on Wednesday, October 25th. The stock was acquired at an average cost of GBX 1,518 ($20.59) per share, with a total value of £7,180.14 ($9,737.10). Over the last ninety days, insiders purchased 502 shares of company stock valued at $756,702.

COPYRIGHT VIOLATION NOTICE: “GlaxoSmithKline (GSK) Given “Buy” Rating at Liberum Capital” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3143391/glaxosmithkline-gsk-given-buy-rating-at-liberum-capital.html.

About GlaxoSmithKline

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Analyst Recommendations for GlaxoSmithKline (LON:GSK)

Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.